Will Johnson and Johnson's COVID-19 vaccine receive FDA approval or Emergency Use Authorization (EUA) by March 15, 2021?

Resolution criteria

This is a market on whether Johnson and Johnson's COVID-19 vaccine will receive regulatory approval in the USA in the form of either FDA approval OR Emergency Use Authorization, whichever comes first. This market will resolve to “Yes” if Johnson and Johnson's COVID-19 vaccine receives FDA approval or EUA prior to the resolution date, March 15, 2021, 12:00 pm EST, and "No" otherwise. This market will be resolved in good faith, according to the FDA list of licensed vaccines (https://www.fda.gov/vaccines-blood-biologics/vaccines/vaccines-licensed-use-united-states), the FDA EUA list (https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization), as well as any other resolution source deemed appropriate by the Markets Integrity Committee (MIC).